Thanks to the contributors of this document:Lora Joyner, Chair Amanda Kilgore, Vice ChairRyan Rushton, Cindy Bailey, Bruno Steiner, Kim Baumann, Pattye Tobase, and PTWG 2022 members This material is provided for your general information only.…
General Information
Registration is required for this event. Reserve your spot in the club today!
When: July 29th, 2pm – 3pm EST on Zoom
After registering, you will receive a confirmation email containing information about joining the…
Objectives:
To determine the relationship between von Willebrand disease (vWD), dental plaque, and gingival bleeding in women with vWD and to determine the oral hygiene habits and dental care…
Aim:
The goal of this project was to gather data and identify factors affecting access to dental care for people with bleeding disorders in the United States.
Methods:
The Arizona School of…
Sanofi has announced positive results from their pivotal LUNA 3 study, a phase 3 clinical trial of rilzabrutinib, the company’s investigational oral therapy developed to treat persistent or chronic primary immune thrombocytopenia (ITP). Primary…
A new review published in the European Journal of Haematology describes the challenges inherent in managing both bleeding and excessive clot risk in patients with primary immune thrombocytopenia (ITP). Primary ITP is a rare…
Akorn Pharmaceuticals, one of several companies that manufactures and markets the product aminocaproic acid, recently filed for chapter 7 bankruptcy and subsequently closed. For those unfamiliar with the product, aminocaproic acid is an…
Newly published findings suggest positive results from a late-stage clinical trial on a much-needed treatment option for young people with persistent or chronic primary immune thrombocytopenia (ITP).ITP is a rare…
Takeda recently announced positive results from a phase 2 clinical trial of their investigational therapy (Mezagitamab), to treat patients with persistent or chronic primary immune thrombocytopenia (ITP). The therapy is developed with laboratory…
Government Relations Update – August 2024 Federal Medicaid Unwinding As part of the COVID-19 public health emergency (PHE), state Medicaid programs were not allowed to conduct…